Rational Design and Construction of Viral Based Products
Recent news
Israeli viral vaccines co SynVaccine raises $1.7m
-17m-1001210612
01 Oct, 2017
SynVaccine has recently been awarded the European Commission`s Horizon 2020 SME Instrument Phase 1 grant
28 June, 2017
Second prize award in the ITTN start-up competition
25 May, 2016
SynVaccine finalist at the Berlin Falling Walls Venture competition, one of 3 top science based start-ups of 2014
December 2014
SynVaccine has been declared one of 3 top science based start-up of the Year (2014) by the a jury of 18 leaders from industry, investment and academics at the Falling Walls Venture competition.
More than 25 outstanding science based start-up companies from around the world presented their business ideas at the global forum Falling Walls Venture in Berlin. Nominated by leading international academic institutions and venture capitalists, each start-up had only five minutes to convince a distinguished jury of their business concepts. SynVaccine was chosen to be one of the three most promising start-ups of the year 2014.